Clinical Trials
In a recent pilot study on female postmenopausal
subjects at National University of Singapore, MPGMA was found to be safe and
well tolerated in 18 weeks of treatment. Patients were followed up for one
year. In this study, the trend in efficacy is clear. MPGMA
is found to
preserve the bone mineral density in the hips.
|
5 / 6 |
 |
 |
